Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
Key facts
- Who runs it
- CMH Multan Institute of Medical Sciences
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 60 people enrolled
- Started
- 1 Feb 2024
- Ended
- 30 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Iron Carboxymaltose
- Iron Sucrose Injection
- Record updated
- 6 April 2025
Who can take part
- Age
- 20 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- 28-34 weeks of gestation
- Iron deficiency anemia (IDA): IDA will be labelled if Hemoglobin is <10 gm% and serum Ferritin < 30 ng/ml
Who cannot take part
- history of allergic reaction to intravenous iron infusion
- Hepatitis (serum transaminases more than 1.5 times the upper limit of normal) and HIV infection
- serum creatinine level of more than 2.0 mg/dL
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical trial aimed to determine whether intravenous ferric carboxymaltose is more useful than iron sucrose for treating anemia in pregnant women.
Read full original descriptionShow less
The main question it aimed to answer was:
Is intravenous ferric carboxymaltose is more useful than iron sucrose for treating iron deficiency anemia in pregnant women.
Sixty pregnant women with iron deficiency anemia were enrolled to one of two intravenous treatments.
* Participants in ferrous carboxymaltose group received a maximum dose of 1000 mg per sitting diluted in 200 ml 0.9% normal saline and administered as an IV infusion over 30 min. * Participants in iron sucrose group were administered an infusion of 300 mg in 200 ml NS over 15-20 min twice weekly till dosage was completed, not exceeding 600 mg per week.
The 2 groups in the trial
- CarboxymaltoseTreatment being tested
Intravenous infusion
Treatment: Iron Carboxymaltose
- SucroseExisting treatment, for comparison
Intravenous infusion
Treatment: Iron Sucrose Injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anemia in Pregnant Women
- Record updated
- 6 April 2025